Jonetta J Mpofu1,2, Fatma Soud3, Meghan Lyman4, Alimamy P Koroma5, Diane Morof1,2, Sascha Ellington1, Samuel S Kargbo5, William Callaghan1. 1. Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA. 2. US Public Health Service Commissioned Corps, Rockville, MD, USA. 3. Zambia Country Office, Centers for Disease Control and Prevention, Lusaka, Zambia. 4. Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Office of Public Health Scientific Services, Centers for Disease Control and Prevention, Atlanta, GA, USA. 5. Ministry of Health and Sanitation, Freetown, Sierra Leone.
Abstract
OBJECTIVES: To examine Ebola virus disease (EVD) symptom prevalence and EVD status among pregnant women in Ebola isolation units in Sierra Leone. METHODS: In an observational study, data were obtained for pregnant women admitted to Ebola isolation units across four districts in Sierra Leone from June 29, 2014, to December 20, 2014. Women were admitted to isolation units if they had suspected EVD exposures or fever (temperature >38°C) and three or more self-reported symptoms suggestive of EVD. Associations were examined between EVD status and each symptom using χ2 tests and logistic regression adjusting for age/labor status. RESULTS: Of 176 pregnant women isolated, 55 (32.5%) tested positive for EVD. Using logistic regression models adjusted for age, EVD-positive women were significantly more likely to have fever, self-reported fatigue/weakness, nausea/vomiting, headache, muscle/joint pain, chest pain, vaginal bleeding, unexplained bleeding, or sore throat upon admission. In models adjusted for age/labor, only women with fever or vaginal bleeding upon admission were significantly more likely to be EVD-positive. CONCLUSIONS: Several EVD symptoms and complications increased the odds of testing EVD-positive; some of these were also signs and symptoms of labor/pregnancy complications. The study results highlight the need to refine screening for pregnant women with EVD.
OBJECTIVES: To examine Ebola virus disease (EVD) symptom prevalence and EVD status among pregnant women in Ebola isolation units in Sierra Leone. METHODS: In an observational study, data were obtained for pregnant women admitted to Ebola isolation units across four districts in Sierra Leone from June 29, 2014, to December 20, 2014. Women were admitted to isolation units if they had suspected EVD exposures or fever (temperature >38°C) and three or more self-reported symptoms suggestive of EVD. Associations were examined between EVD status and each symptom using χ2 tests and logistic regression adjusting for age/labor status. RESULTS: Of 176 pregnant women isolated, 55 (32.5%) tested positive for EVD. Using logistic regression models adjusted for age, EVD-positive women were significantly more likely to have fever, self-reported fatigue/weakness, nausea/vomiting, headache, muscle/joint pain, chest pain, vaginal bleeding, unexplained bleeding, or sore throat upon admission. In models adjusted for age/labor, only women with fever or vaginal bleeding upon admission were significantly more likely to be EVD-positive. CONCLUSIONS: Several EVD symptoms and complications increased the odds of testing EVD-positive; some of these were also signs and symptoms of labor/pregnancy complications. The study results highlight the need to refine screening for pregnant women with EVD.
Authors: F M Baggi; A Taybi; A Kurth; M Van Herp; A Di Caro; R Wölfel; S Günther; T Decroo; H Declerck; S Jonckheere Journal: Euro Surveill Date: 2014-12-11
Authors: Elhadj Ibrahima Bah; Marie-Claire Lamah; Tom Fletcher; Shevin T Jacob; David M Brett-Major; Amadou Alpha Sall; Nahoko Shindo; William A Fischer; Francois Lamontagne; Sow Mamadou Saliou; Daniel G Bausch; Barry Moumié; Tim Jagatic; Armand Sprecher; James V Lawler; Thierry Mayet; Frederique A Jacquerioz; María F Méndez Baggi; Constanza Vallenas; Christophe Clement; Simon Mardel; Ousmane Faye; Oumar Faye; Baré Soropogui; Nfaly Magassouba; Lamine Koivogui; Ruxandra Pinto; Robert A Fowler Journal: N Engl J Med Date: 2014-11-05 Impact factor: 91.245
Authors: Boris I Pavlin; Andrew Hall; Jan Hajek; Muhammad Ali Raja; Vikas Sharma; Otim Patrick Ramadan; Sharmistha Mishra; Audrey Rangel; Aileen Kitching; Katrina Roper; Tim O'Dempsey; Judith Starkulla; Amy Elizabeth Parry; Rashida Kamara; Alie H Wurie Journal: Int J Infect Dis Date: 2020-05-22 Impact factor: 3.623
Authors: Nzelle D Kayem; Charlotte Benson; Christina Y L Aye; Sarah Barker; Mariana Tome; Stephen Kennedy; Proochista Ariana; Peter Horby Journal: Trans R Soc Trop Med Hyg Date: 2022-06-01 Impact factor: 2.455
Authors: Grazia Caleo; Foivi Theocharaki; Kamalini Lokuge; Helen A Weiss; Leena Inamdar; Francesco Grandesso; Kostas Danis; Biagio Pedalino; Gary Kobinger; Armand Sprecher; Jane Greig; Gian Luca Di Tanna Journal: Lancet Infect Dis Date: 2020-06-25 Impact factor: 71.421